News
12 May 2026
Frost & Sullivan’s 2026 Global Company of the Year
Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.
30 October 2024
Avance Clinical signs MOUs with key Korean trial sites at 2024 KoNECT
Avance Clinical is proud to announce the signing of three significant Memorandums of Understanding (MOUs) with key Korean clinical sites during KoNECT 2024 conference.
15 October 2024
Avance Clinical Welcomes Kelly Yang as Associate Director, Operations Taiwan
Kelly brings over 15 years of experience in the pharmaceutical and clinical research industries, making her a valuable addition to Avance Clinical’s growing team.
16 September 2024
Avance Clinical CEO Yvonne Lungershausen Named Finalist for CEO of the Year Award in Healthcare
Avance Clinical is delighted to announce that our CEO, Yvonne Lungershausen, has been named a finalist in The CEO Magazine’s 2024 Executive of the Year Awards in the Healthcare category. This nomination celebrates Yvonne’s exceptional leadership, innovative vision, and her commitment to advancing biotechnology research globally.
4 September 2024
Avance Clinical GlobalReady Site Partnership Network Expands Rapidly to 2,000 Site Members
Avance Clinical, the award-winning market-leading CRO for biotechs, announced today that 2,000 clinical sites across North America had joined the Avance Clinical GlobalReady Site Partnership Network.
27 August 2024
Avance Clinical Wins 2024 Frost & Sullivan Award for Global Biotech CRO Excellence
Avance Clinical, a leading global CRO specializing in clinical trials for the biotech sector, has won the prestigious 2024 Frost & Sullivan Best Practices Customer Value Leadership Award for Global Biotech CRO Excellence.
20 August 2024
Avance Clinical Wins Premier’s Business and Export Awards 2024
Avance Clinical is thrilled to announce that it has again been named as a winner in the prestigious South Australian Premier’s Business and Export Awards 2024. This honor underscores Avance Clinical’s continued commitment to driving innovation and delivering world-class clinical trial solutions to the global market, and comes on the heels of winning the 2023 International Health Exporter of the Year at last year’s awards ceremony.
12 August 2024
Avance Clinical Signs MOU with Mid-Ship Biomedical to Strengthen Global Clinical Research Collaboration
Avance Clinical Signs MOU with Mid-Ship Biomedical to Strengthen Global Clinical Research Collaboration
22 July 2024
Avance Clinical Appoints Asia Regional Director as Part of Global Expansion Program
Avance Clinical, the award-winning CRO for biotechs, is proud to announce the appointment of Jessica Han as Director, Asian Operations based out of the Avance Clinical’s Seoul, Korea office.
28 June 2024
Avance Clinical Welcomes Joe Taouk as Vice President, Global Project Delivery
Avance Clinical, a leading Contract Research Organization (CRO) renowned for its innovative solutions in the biotech industry, is excited to announce the appointment of Joe Taouk as Vice President, Global Project Delivery.
4 June 2024
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Deliver 30% Savings, Halve Timelines and Cut Risk for Biotechs
Avance Clinical is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs.
28 May 2024
Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical
Avance Clinical has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS and rare diseases specialist CRO with extensive site relationships in the region.
9 May 2024
Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea – Seoul Office Announced at BIO Korea 2024
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open new clinical operations in Seoul, South Korea.
Proven industry
experience & expertise
500+
Studies in the past 5 years
450+
Experienced team members
18k+
Participants past 5 years
30
Years of CRO experience